Position in REGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,245,525
-$181,132 QoQ
Shares Held
5,205
+17.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#443
of 1,322 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2026CallValue
$1,060,018
CallShares
1,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $12,683,379 across 13 Biotechnology names. REGN ranks #1 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,205 | $3,245,525 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
9,439 | $2,274,514 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,330 | $1,654,110 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
20,646 | $1,615,961 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
49,336 | $1,575,791 | |
| 6 | MRNA |
Moderna, Inc.
|
15,033 | $1,052,760 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
10,487 | $571,960 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
8,866 | $313,767 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,245,525 | 5,205 | Shares | Sole | 2026-08-10 | |
| 2026-06-30 | $1,060,018 | 1,700 | Call | Sole | 2026-08-10 | |
| 2026-03-31 | $1,004,432 | 1,300 | Call | Sole | 2026-05-18 | |
| 2026-03-31 | $3,426,657 | 4,435 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $77,187 | 100 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $2,509,349 | 3,251 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $308,748 | 400 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $1,124,539 | 2,000 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,071,000 | 2,040 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $259,399 | 409 | Shares | Sole | 2025-05-08 | |
| 2024-06-30 | $212,308 | 202 | Shares | Sole | 2024-07-29 | |
| 2021-09-30 | $33,890 | 56 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $31,836 | 57 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $13,721 | 29 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,415 | 5 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $8,956 | 16 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $9,978 | 16 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $7,812 | 16 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||